770 NEW ZEALAND GAZETTE, No. 32 3 FEBRUARY 2005

Silver; except in oral solutions containing 0.3% or less or
other medicines containing 1% or less
Silver sulfadiazine; for external use in packs containing
50 grams or less
Sodium picosulfate; for laxative use
*Triamcinolone; in aqueous nasal sprays delivering up to
55 micrograms per actuation when the maximum daily
dose is no greater than 220 micrograms and the medicine
has received the consent of the Minister or the Director-
General to its distribution as a pharmacy-only medicine

Medicines for General Sale

Please note that the following medicines are no longer
classified as prescription medicines, restricted medicines or
pharmacy-only medicines. As such, they are now available
for general sale.

Acetylcysteine; for external use; for oral use in medicines
containing 1 gram or less per recommended daily dose
Aciclovir; for external use for the treatment of herpes
labialis in medicines containing 5% or less and tubes
containing 3 grams or less
Bamyphylline
Benzamine
Benzyl benzoate
Bifonazole; for external use in medicines for tinea pedis
only or in shampoos containing 1% or less
Butyl aminobenzoate; in medicines for dermal use
containing 2% or less
Collagen; except in injections or implantations for tissue
augmentation or cosmetic use
Dextromethorphan; in liquid form containing 0.25% or less
or in solid dose form containing 15 milligrams or
less per dose form when in packs containing not more
than 600 milligrams and with a recommended daily dose
of not more than 120 milligrams
Dichlofenthion
Diprophylline
Ephedra navadensis
Fluorides; in pastes, gels or powders for cleaning the teeth
containing 0.1% or less; in oral hygiene products
other than pastes, gels or powders for cleaning the
teeth containing 0.01% or less; in parenteral nutrition
replacement preparations; in medicines containing
15 milligrams or less per litre or per kilogram
Folic acid; for oral use in medicines containing 500
micrograms or less per recommended daily dose
Folinic acid; for oral use in medicines containing 500
micrograms or less per recommended daily dose
Gadobenic acid
Gadobutrol

Guaiphenesin; for oral use in medicines containing 2% or
less or 200 milligrams or less
Hyaluronic acid; except in injections or implantations for
tissue augmentation or cosmetic use
Hydroquinone; for external use in hair preparations
containing 1% or less
Hylan polymer; except in injections or implantations for
tissue augmentation or cosmetic use
Hyoscyamus niger; in packs containing 30 micrograms or
less of total solanaceous alkaloids
*Ibuprofen; for external use; for oral use in solid dose form
containing 200 milligrams or less per dose form when in
packs containing not more than 25 dose units and when
in medicines which have received the consent of the
Minister or the Director-General to their sale as general
sale medicines and which are sold in the manufacturer’s
original pack
Injectable medicines; except when specified in the First
Schedule to the Medicines Regulations
Ketoprofen; for external use
Mandelic acid
Monosulfiram
Oxedrine; in medicines containing 30 milligrams or less per
recommended daily dose
Reproterol
Sabadilla; in packs containing 1.8 milligrams or less with
a recommended daily dose of not more than 0.6
milligrams of total alkaloids
Salicylic acid; in medicines containing 40% or less
Silver; in oral solutions containing 0.3% or less or other
medicines containing 1% or less
Terebene
Tetrastarch
Trichloroacetic acid; for external use in medicines
containing 12.5% or less for the treatment of warts other
than anogenital warts

*Regulation 20 of the Medicines Regulations 1984 requires
that all medicines sold without a practitioner’s prescription
must include a consumer information panel on the label.
Further, all material changes to a medicine (including changes
to labelling) must be notified to the Director-General of
Health in accordance with section 24 of the Medicines Act
1981.

Dated this 25th day of January 2005.

DON MATHESON, Deputy Director-General, Public Health
Directorate.

go595

Inland Revenue

Income Tax Act 2004

National Standard Costs for Specified Livestock
Determination, 2005

This determination may be cited as The National Standard
Costs for Specified Livestock Determination, 2005.
This determination is made in terms of section EC 23 of
the Income Tax Act 2004.

It shall apply to any specified livestock on hand at the end
of the 2004-2005 income year where the taxpayer has
elected to value that livestock under the national standard
cost scheme for that income year.

For the purposes of section EC 23 of the Income Tax Act
2004, the national standard costs for specified livestock, for
the 2004-2005 income year, are as set out in the following
table.

Table